10-hydroxy-1-(1,2,3,6-tetrahydropyridin-4-yl)-10-(trifluoromethyl)anthracen-9(10H)-one hydrochloride

ID: ALA4446071

PubChem CID: 154697556

Max Phase: Preclinical

Molecular Formula: C20H17ClF3NO2

Molecular Weight: 359.35

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cl.O=C1c2ccccc2C(O)(C(F)(F)F)c2cccc(C3=CCNCC3)c21

Standard InChI:  InChI=1S/C20H16F3NO2.ClH/c21-20(22,23)19(26)15-6-2-1-4-14(15)18(25)17-13(5-3-7-16(17)19)12-8-10-24-11-9-12;/h1-8,24,26H,9-11H2;1H

Standard InChI Key:  DKBGROYJGLTPPF-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
   20.2726  -20.4769    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   18.4603  -25.7226    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0517  -25.0097    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6386  -25.7200    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.9116  -23.7715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9105  -24.5994    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6256  -25.0124    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6238  -23.3586    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3396  -23.7679    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3385  -24.5969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0541  -23.3521    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7720  -23.7699    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7704  -24.5952    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4831  -25.0075    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1980  -24.5957    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1957  -23.7672    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4823  -23.3587    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0541  -22.5266    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.4804  -22.5332    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1927  -22.1216    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1910  -21.2969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4747  -20.8850    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.7584  -21.3039    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7635  -22.1271    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0452  -26.4362    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   19.2858  -25.7253    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   18.8688  -26.4356    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  3  2  1  0
  4  3  1  0
  5  6  2  0
  6  7  1  0
  7 10  2  0
  9  8  2  0
  8  5  1  0
  9 10  1  0
  9 11  1  0
 10  3  1  0
  3 13  1  0
 12 11  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 11 18  2  0
 17 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 19  1  0
  2 25  1  0
  2 26  1  0
  2 27  1  0
M  END

Associated Targets(Human)

PDK4 Tchem Pyruvate dehydrogenase kinase isoform 4 (177 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 359.35Molecular Weight (Monoisotopic): 359.1133AlogP: 3.41#Rotatable Bonds: 1
Polar Surface Area: 49.33Molecular Species: BASEHBA: 3HBD: 2
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 9.86CX Basic pKa: 9.22CX LogP: 2.60CX LogD: 1.21
Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.82Np Likeness Score: 0.33

References

1. Lee D, Pagire HS, Pagire SH, Bae EJ, Dighe M, Kim M, Lee KM, Jang YK, Jaladi AK, Jung KY, Yoo EK, Gim HE, Lee S, Choi WI, Chi YI, Song JS, Bae MA, Jeon YH, Lee GH, Liu KH, Lee T, Park S, Jeon JH, Lee IK, Ahn JH..  (2019)  Discovery of Novel Pyruvate Dehydrogenase Kinase 4 Inhibitors for Potential Oral Treatment of Metabolic Diseases.,  62  (2): [PMID:30623649] [10.1021/acs.jmedchem.8b01168]

Source